These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25000235)

  • 21. Path test reactions to the Chinese Standard Screening Allergens in 1,135 patients investigated for allergic contact dermatitis.
    Liu YQ; Zhao B; Zhuang LH; Fan WX
    Am J Contact Dermat; 1997 Sep; 8(3):141-3. PubMed ID: 9249281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept.
    Van Lümig PP; Lecluse LL; Driessen RJ; Spuls PI; Boezeman JB; van de Kerkhof PC; De Jong EM
    Br J Dermatol; 2010 Oct; 163(4):838-46. PubMed ID: 20649798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. North American Contact Dermatitis Group patch-test results, 2003-2004 study period.
    Warshaw EM; Belsito DV; DeLeo VA; Fowler JF; Maibach HI; Marks JG; Toby Mathias CG; Pratt MD; Rietschel RL; Sasseville D; Storrs FJ; Taylor JS; Zug KA
    Dermatitis; 2008; 19(3):129-36. PubMed ID: 18627684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study.
    Esposito M; Giunta A; Mazzotta A; Zangrilli A; Babino G; Bavetta M; Perricone R; Chimenti S; Chimenti MS
    Dermatology; 2012; 225(4):312-9. PubMed ID: 23295383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monitoring psoriasis patients being treated with tumour necrosis factor inhibitors: use your judgment.
    Feldman SR
    Br J Dermatol; 2011 Aug; 165(2):229-30. PubMed ID: 21777211
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment patterns in the first year after initiating tumor necrosis factor blockers in real-world settings.
    Bonafede M; Fox KM; Watson C; Princic N; Gandra SR
    Adv Ther; 2012 Aug; 29(8):664-74. PubMed ID: 22886712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patch-test results of the North American Contact Dermatitis Group 2005-2006.
    Zug KA; Warshaw EM; Fowler JF; Maibach HI; Belsito DL; Pratt MD; Sasseville D; Storrs FJ; Taylor JS; Mathias CG; Deleo VA; Rietschel RL; Marks J
    Dermatitis; 2009; 20(3):149-60. PubMed ID: 19470301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positive patch-test reactions to mixed dialkyl thioureas: cross-sectional data from the North American Contact Dermatitis Group, 1994 to 2004.
    Warshaw EM; Cook JW; Belsito DV; DeLeo VA; Fowler JF; Maibach HI; Marks JG; Mathias CG; Pratt MD; Rietschel RL; Sasseville D; Storrs FJ; Taylor JS; Zug KA;
    Dermatitis; 2008; 19(4):190-201. PubMed ID: 18674454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disability outcomes and dose escalation with etanercept, adalimumab, and infliximab in rheumatoid arthritis patients: a US-based retrospective comparative effectiveness study.
    Schabert VF; Bruce B; Ferrufino CF; Globe DR; Harrison DJ; Lingala B; Fries JF
    Curr Med Res Opin; 2012 Apr; 28(4):569-80. PubMed ID: 22236091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patch testing reactions to a standard series in 608 patients tested from 1990 to 1997 at Massachusetts General Hospital.
    Albert MR; González S; González E
    Am J Contact Dermat; 1998 Dec; 9(4):207-11. PubMed ID: 9810020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-α inhibitors: the Mayo Clinic experience, 1998 to 2010.
    Shmidt E; Wetter DA; Ferguson SB; Pittelkow MR
    J Am Acad Dermatol; 2012 Nov; 67(5):e179-85. PubMed ID: 21752492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. North American Contact Dermatitis Group patch test results for 2007-2008.
    Fransway AF; Zug KA; Belsito DV; Deleo VA; Fowler JF; Maibach HI; Marks JG; Mathias CG; Pratt MD; Rietschel RL; Sasseville D; Storrs FJ; Taylor JS; Warshaw EM; Dekoven J; Zirwas M
    Dermatitis; 2013; 24(1):10-21. PubMed ID: 23340394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment effect of adalimumab and infliximab in Japanese psoriasis patients: results in a single community-based hospital.
    Noda S; Mizuno K; Adachi M
    J Dermatol; 2012 Mar; 39(3):265-8. PubMed ID: 22126280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective study.
    Fouache D; Goëb V; Massy-Guillemant N; Avenel G; Bacquet-Deschryver H; Kozyreff-Meurice M; Ménard JF; Muraine M; Savoye G; Le Loët X; Tharasse C; Vittecoq O
    Rheumatology (Oxford); 2009 Jul; 48(7):761-4. PubMed ID: 19395543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patch testing a patient with allergic contact hand dermatitis who is taking infliximab.
    Rosmarin D; Bush M; Scheinman PL
    J Am Acad Dermatol; 2008 Jul; 59(1):145-7. PubMed ID: 18468722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of patch testing to personal care product allergens in a standard series and a supplemental cosmetic series: an analysis of 945 patients from the Mayo Clinic Contact Dermatitis Group, 2000-2007.
    Wetter DA; Yiannias JA; Prakash AV; Davis MD; Farmer SA; el-Azhary RA
    J Am Acad Dermatol; 2010 Nov; 63(5):789-98. PubMed ID: 20643495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry.
    Inzinger M; Heschl B; Weger W; Hofer A; Legat FJ; Gruber-Wackernagel A; Tilz H; Salmhofer W; Quehenberger F; Wolf P
    Br J Dermatol; 2011 Sep; 165(3):640-5. PubMed ID: 21564068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis.
    Malajian D; Belsito DV
    J Am Acad Dermatol; 2013 Aug; 69(2):232-7. PubMed ID: 23583066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occupationally related contact dermatitis in North American food service workers referred for patch testing, 1994 to 2010.
    Warshaw EM; Kwon GP; Mathias CG; Maibach HI; Fowler JF; Belsito DV; Sasseville D; Zug KA; Taylor JS; Fransway AF; Deleo VA; Marks JG; Pratt MD; Storrs FJ; Zirwas MJ; Dekoven JG
    Dermatitis; 2013; 24(1):22-8. PubMed ID: 23340395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Etanercept-induced asthma in a psoriatic patient resolving with transition to ustekinumab.
    Torres T; Vilaça S; Velho G; Selores M
    Eur J Dermatol; 2012; 22(5):696-7. PubMed ID: 22910198
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.